Matches in SemOpenAlex for { <https://semopenalex.org/work/W2760987043> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2760987043 abstract "e15080 Background: Currently, sunitinib has been recommended as the primary treatment in the patients with metastatic renal cell carcinoma (mRCC) among the vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI). However, there are no published clinical data that compared directly the efficacy of targeted agents in the first line setting, and first-line treatment in mRCC patients is yet to be determined. Methods: To compare the efficacy and toxicities between sorafenib and sunitinb, clinical database was used to identify all patients with mRCC treated with VEGF TKIs in Asan Medical Center from April 2005 to March 2011. Among 304 patients, we identified 49 and 220 patients who were treated first with sorafenib and sunitinib, respectively. Results: The patients in the sorafenib group were older than those in the sunitinib group (62 vs 56.5 years, p=0.019). Disease control rate (DCR) of 82% was achieved in both groups. After a median follow-up duration of 49 months, progression free survival (PFS) and overall survival (OS) were not significantly different (sorafenib vs sunitinib, PFS; 8.6 months vs 9.9 months, p=0.948, OS; 25.7 months and 22.6 months, p=0.774). The patients treated with sorafenib have required dose reduction due to toxicities less frequently than those treated with sunitinib (37% vs 54%, p=0.034). Hematologic toxicities of grade 3 or 4 were more common in sunitinib group (4.2% vs 44.6%, p<0.001), and also was grade 3 or 4 hypertension, although it was not statistically significant (4.2% vs 13.7%, p=0.06). Age (> 60 years), duration from diagnosis to treatment (less than 1 year), Anemia, Neutrophilia, thorombocytosis, bone and liver metastases were independent prognostic factors affecting OS. Multivariate analysis also showed first-line VEGF TKI did not affect OS [hazard ratio (HR, sorafenib vs sunitinib) = 0.94, p=0.774]. Conclusions: Sorafenib showed comparable efficacy to sunitinb and demonstrated superiority in toxicities in the treatment of mRCC patients." @default.
- W2760987043 created "2017-10-20" @default.
- W2760987043 creator A5007931207 @default.
- W2760987043 creator A5007992707 @default.
- W2760987043 creator A5025787561 @default.
- W2760987043 creator A5045648382 @default.
- W2760987043 creator A5047657377 @default.
- W2760987043 creator A5052223687 @default.
- W2760987043 creator A5063838757 @default.
- W2760987043 creator A5072419569 @default.
- W2760987043 creator A5073284312 @default.
- W2760987043 creator A5079154981 @default.
- W2760987043 creator A5079540101 @default.
- W2760987043 date "2012-05-20" @default.
- W2760987043 modified "2023-09-28" @default.
- W2760987043 title "Comparative efficacy of sunitinib versus sorafenib as the first-line treatment for patients with metastatic renal cell carcinoma." @default.
- W2760987043 cites W1522152077 @default.
- W2760987043 cites W1990095055 @default.
- W2760987043 cites W1996283150 @default.
- W2760987043 cites W1999966467 @default.
- W2760987043 cites W2019607817 @default.
- W2760987043 cites W2031048921 @default.
- W2760987043 cites W2034058863 @default.
- W2760987043 cites W2039698853 @default.
- W2760987043 cites W2084778105 @default.
- W2760987043 cites W2096057999 @default.
- W2760987043 cites W2099088585 @default.
- W2760987043 cites W2099752220 @default.
- W2760987043 cites W2138822094 @default.
- W2760987043 cites W2140765540 @default.
- W2760987043 cites W2147186814 @default.
- W2760987043 cites W2147663823 @default.
- W2760987043 cites W2149026055 @default.
- W2760987043 cites W2151507583 @default.
- W2760987043 cites W2160120519 @default.
- W2760987043 cites W2160286488 @default.
- W2760987043 cites W2162225483 @default.
- W2760987043 cites W2166926027 @default.
- W2760987043 cites W2217288524 @default.
- W2760987043 cites W2560779126 @default.
- W2760987043 doi "https://doi.org/10.1200/jco.2012.30.15_suppl.e15080" @default.
- W2760987043 hasPublicationYear "2012" @default.
- W2760987043 type Work @default.
- W2760987043 sameAs 2760987043 @default.
- W2760987043 citedByCount "0" @default.
- W2760987043 crossrefType "journal-article" @default.
- W2760987043 hasAuthorship W2760987043A5007931207 @default.
- W2760987043 hasAuthorship W2760987043A5007992707 @default.
- W2760987043 hasAuthorship W2760987043A5025787561 @default.
- W2760987043 hasAuthorship W2760987043A5045648382 @default.
- W2760987043 hasAuthorship W2760987043A5047657377 @default.
- W2760987043 hasAuthorship W2760987043A5052223687 @default.
- W2760987043 hasAuthorship W2760987043A5063838757 @default.
- W2760987043 hasAuthorship W2760987043A5072419569 @default.
- W2760987043 hasAuthorship W2760987043A5073284312 @default.
- W2760987043 hasAuthorship W2760987043A5079154981 @default.
- W2760987043 hasAuthorship W2760987043A5079540101 @default.
- W2760987043 hasConcept C121608353 @default.
- W2760987043 hasConcept C126322002 @default.
- W2760987043 hasConcept C126894567 @default.
- W2760987043 hasConcept C143998085 @default.
- W2760987043 hasConcept C2777472916 @default.
- W2760987043 hasConcept C2778019345 @default.
- W2760987043 hasConcept C2778695046 @default.
- W2760987043 hasConcept C2778820342 @default.
- W2760987043 hasConcept C2779490328 @default.
- W2760987043 hasConcept C29730261 @default.
- W2760987043 hasConcept C71924100 @default.
- W2760987043 hasConcept C90924648 @default.
- W2760987043 hasConceptScore W2760987043C121608353 @default.
- W2760987043 hasConceptScore W2760987043C126322002 @default.
- W2760987043 hasConceptScore W2760987043C126894567 @default.
- W2760987043 hasConceptScore W2760987043C143998085 @default.
- W2760987043 hasConceptScore W2760987043C2777472916 @default.
- W2760987043 hasConceptScore W2760987043C2778019345 @default.
- W2760987043 hasConceptScore W2760987043C2778695046 @default.
- W2760987043 hasConceptScore W2760987043C2778820342 @default.
- W2760987043 hasConceptScore W2760987043C2779490328 @default.
- W2760987043 hasConceptScore W2760987043C29730261 @default.
- W2760987043 hasConceptScore W2760987043C71924100 @default.
- W2760987043 hasConceptScore W2760987043C90924648 @default.
- W2760987043 hasLocation W27609870431 @default.
- W2760987043 hasOpenAccess W2760987043 @default.
- W2760987043 hasPrimaryLocation W27609870431 @default.
- W2760987043 isParatext "false" @default.
- W2760987043 isRetracted "false" @default.
- W2760987043 magId "2760987043" @default.
- W2760987043 workType "article" @default.